Pfizer's latest COVID booster targets Omicron JN.1. Learn who should get it and why it’s essential for protection.

For young, healthy people who may be wondering, “do I need a COVID booster at all?”, having one annually is sensible.

Australia's Therapeutic Goods Administration has approved a new COVID booster by Pfizer targeting the JN.1 sub-variant of Omicron. Despite evolving variants, boosters remain crucial, especially for ...

Ongoing studies shows why covid 19 protection wanes over time. Know the factors behind waning immunity, why booster doses are ...

The absolute number of COVID-19 deaths was three times higher than those from flu, but the case-fatality ratio was comparable ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved an adapted version of the Nuvaxovid COVID-19 vaccine that targets the ...

Pfizer and partner BioNTech have started their clinical trial of a new version of their COVID-19 vaccine that has been specifically designed to protect against the Omicron variant. The trial in ...

COVID-19 vaccination coverage has progressed unevenly throughout the world. Moreover, 1.01 and 1.43 doses for each person are ...

The vaccine is part of a recommended vaccine regimen for children ... and attempts to address the rise of FLiRT omicron ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

UK researchers have analysed the likely impact that a Covid booster shot will have on Omicron and say it could provide around ...